BioCentury
ARTICLE | Clinical News

NTx-428: Phase IIa started

May 9, 2011 7:00 AM UTC

Stem Cell Therapeutics said investigators began an open-label, Canadian Phase IIa trial to evaluate NTx-428 in 10 patients. ...